Incyte Corporation (NASDAQ:INCY), from Healthcare sector has been on the upside of the performance spectrum.
Incyte Corporation stated a price of 133.67 today, indicating a positive change of -2.98%.
Incyte Corporation is operating with a market capitalization of 27542.7, with a return on assets (ROA) of 7.30% and an average volume of 2485.83.
At present the return on equity (ROE) stands at 31.70% and the debt to equity stands at 0.
(Good to know: Return on Equity [ROE] is the simple measurement of profitability that takes into account how many dollars of profit an organization makes with each dollar of shareholder’s equity.)
The 52-week high for Incyte Corporation stands at -12.72% while the 52-week low stands at 96.49%.
The performance week for Incyte Corporation is at -4.28% and the performance month is at 0.66%. The quarterly and half-yearly performance stats stands at 31.10% and 44.84% respectively.
The performance (Year to Date) is at 33.31%.
The simple 20 day moving average for Incyte Corporation is -6.02% and the simple 200-day moving average is at 32.11%.
The volatility (week) for Incyte Corporation is at 2.36% and the volatility (month) is at 3.11%
(Good to know: Volatility in finance basically means the degree of disparity of a trading price series over time as calculated by the standard deviation of returns.)
Incyte Corporation’s short ratio is currently at 3.51 and the float short is at 4.30%.
Incyte Corporation’s P/E ratio currently stands at 248.46, while the P/S ratio is at 24.91 and the potential growth rate of earnings per share this year is at -44.40%.